Guardant Health
GH
#2646
Rank
โ‚น435.80 B
Marketcap
โ‚น3,531
Share price
-5.71%
Change (1 day)
124.37%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -โ‚น403.00

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น426.61. In 2022 the company made an earnings per share (EPS) of -โ‚น556.07 a decrease over its 2021 EPS that were of -โ‚น347.54.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น403.00-27.53%
2022-โ‚น556.0760%
2021-โ‚น347.5455.04%
2020-โ‚น224.17207.14%
2019-โ‚น72.98-19.81%
2018-โ‚น91.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น418.79-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.37-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA